These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35370456)

  • 1.
    Xue J; Zhu X; Qiao X; Wang Y; Bu J; Zhang X; Ma Q; Liang L; Sun L; Liu C
    Int J Med Sci; 2022; 19(3):434-445. PubMed ID: 35370456
    [No Abstract]   [Full Text] [Related]  

  • 2. Phyto-targeting the CEMIP Expression as a Strategy to Prevent Pancreatic Cancer Metastasis.
    Periyasamy L; Muruganantham B; Park WY; Muthusami S
    Curr Pharm Des; 2022; 28(11):922-946. PubMed ID: 35236267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker.
    Dong X; Yang Y; Yuan Q; Hou J; Wu G
    Front Genet; 2021; 12():768140. PubMed ID: 34966410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
    Wu J
    Cancer Biomark; 2020; 29(1):89-99. PubMed ID: 32568178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
    Chen B; Zhang S; Li Q; Wu S; He H; Huang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.
    Liu L; Yang J; Wang C
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
    Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
    Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
    Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
    Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhu X; Zhang Y; Bai Y; Gu X; Chen G; Sun L; Wang Y; Qiao X; Ma Q; Zhu T; Bu J; Xue J; Liu C
    Int J Med Sci; 2020; 17(17):2773-2789. PubMed ID: 33162805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
    Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
    Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
    Wu HT; Liu J; Li GW; Shen JX; Huang YT
    Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer.
    Liu Y; Pan B; Qu W; Cao Y; Li J; Zhao H
    Cancer Cell Int; 2021 Feb; 21(1):130. PubMed ID: 33622332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Fibroblast Growth Factor Receptor (FGFR) Family Genes in Breast Cancer by Integrating Online Databases and Bioinformatics.
    Zhou Z; Wu B; Tang X; Ke R; Zou Q
    Med Sci Monit; 2020 May; 26():e923517. PubMed ID: 32381997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.
    Fink SP; Myeroff LL; Kariv R; Platzer P; Xin B; Mikkola D; Lawrence E; Morris N; Nosrati A; Willson JK; Willis J; Veigl M; Barnholtz-Sloan JS; Wang Z; Markowitz SD
    Oncotarget; 2015 Oct; 6(31):30500-15. PubMed ID: 26437221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
    Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
    J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.